When Non-Conforming Goods Arrive: Quarantine, Rework, Return, or Disposal?
A shipment can look normal at delivery and still contain the wrong model, a missing warning, damaged packaging, a failed inspection, a product-safety concern, or an official notice. The first mistake is to treat all of those as a routine supplier dispute. Detected nonconforming goods arrival is a fact-and-status problem before it becomes a remedy decision.
Detected nonconforming goods arrival means an importer or buyer has identified goods that may differ from an approved specification, commercial commitment, safety requirement, regulatory expectation, or agency instruction after arrival. The first priority in detected nonconforming goods arrival is to preserve facts, control affected inventory, and identify the authority and status. It is not a universal instruction to rework, return, export, destroy, or sell the goods.
For detected nonconforming goods arrival, control the goods before choosing the remedy.
Table of contents
- What does detected nonconforming goods arrival actually mean?
- What should happen during the first containment step?
- Which records belong in the nonconformance fact file?
- How should quarantine, rework, return, export, and disposal be compared?
- How do CBP and other-agency actions change the response?
- What changes when FDA has detained or refused the goods?
- How should supplier corrective action and commercial claims be documented?
- When can a warehouse issue become a wider consumer-safety issue?
- What are the limits of an operational decision matrix?
- Frequently asked questions
What does detected nonconforming goods arrival actually mean?
The word “nonconforming” has several meanings in import operations. It can describe the wrong color, dimensions, quantity, label, package, or product configuration under a purchase order. It can also describe a failed inspection, a technical test concern, a product-safety issue, a customs detention, an FDA Notice of Detention and Hearing, an FDA refusal, or a post-sale complaint. Each status has different evidence needs and different people who may need to be involved.
Para detected nonconforming goods arrival, do not rely on a logistics message that says “held” or a supplier message that says “minor issue.” Find the official notice, receiving record, inspection report, customer complaint, or product specification that triggered the concern. Record who identified it, when, where the goods sit, and whether any units have already been distributed.
Under 19 CFR 151.16, a CBP detention notice is not a final admissibility determination. The notice identifies the detention’s stated reason, anticipated length, tests or inquiries, and information that could accelerate disposition. The rule also says it does not apply to detentions CBP effects on behalf of another government agency with admissibility authority. [1] That distinction is essential: a commercial warehouse hold, CBP detention, FDA action, and final refusal are not labels for the same event.
| Situation | Primary question | Evidence to preserve | First operational control |
|---|---|---|---|
| Commercial specification mismatch | Does the delivered product differ from the purchase order or approved sample? | Order, approved specification, photos, receiving/inspection record, lot and quantity | Separate affected stock and stop routine release while facts are checked |
| Product-safety or test concern | Does the issue indicate a hazard, rule mismatch, or evidence gap? | Product, labels, lot, test record, complaint/inspection evidence, sample history | Preserve units and escalate to appropriate technical and safety reviewers |
| CBP examination or detention | What does the official CBP notice say, and what authority applies? | Notice, entry data, broker correspondence, product/label records | Follow the stated channel and do not alter or move goods without appropriate authority |
| FDA detention | What charges and response date appear on the Notice of Detention and Hearing? | Notice, entry file, stated charges, evidence, contacto record | Preserve the notice and obtain qualified FDA/import guidance before substantive response |
| FDA refusal | Is there a final Notice of Refusal of Admission and stated disposition instruction? | Refusal notice, agency/CBP instructions, custody/location record | Follow the notice and obtain qualified guidance; do not treat it as a normal supplier return |
| Post-sale consumer issue | Which lots, channels, customers, and product versions may be involved? | Complaint, returned item, lot traceability, sales/distribution records | Stop further affected distribution and assess safety/reporting obligations with qualified support |
Detected nonconforming goods arrival needs precise names. For detected nonconforming goods arrival, naming the condition correctly is the first way to avoid a commercially costly or legally risky response.
What should happen during the first containment step?
Containment protects the goods, evidence, and customer. It means pausing normal release of the affected stock, identifying its physical location, separating it from available inventory, and recording its condition. It does not mean making a legal conclusion acerca de the product or deciding it should be destroyed.
For detected nonconforming goods arrival, create a controlled hold record. Include the product and SKU, lot/batch/run, units affected, warehouse location, carton/pallet references, order and shipment details, discovery date/time, person reporting the issue, images, short factual description, and any agency or customer notice. Mark the stock so normal picking, sales, transfer, rework, or disposal cannot occur by accident.
Preserve the condition found. Photograph products, packaging, labels, lot codes, seals, pallets, and any visible damage before sorting or moving them. Keep original delivery records, inspection documents, test materials, communications, and supplier statements. If a retained sample exists, identify it but do not call it conclusive evidence of every unit.
| Containment action | Why it matters | Record to create | Action to avoid |
|---|---|---|---|
| Stop release or sale of affected stock | Prevents further distribution while the scope is unknown | Inventory hold record with SKU, lot, quantity, location, owner | Continuing fulfillment because the issue “looks cosmetic” |
| Separate affected units | Keeps stock from being mixed with conforming inventory | Warehouse location and physical segregation record | Repacking or commingling lots before the scope is documented |
| Preserve condition | Allows later comparison and qualified evaluation | Dated photos, video, condition notes, package/label images | Relabeling, repairing, discarding, or cleaning evidence before review |
| Preserve documents | Maintains the link to supplier, shipment, specification, and authority | Notice file, order, invoice, packing list, inspection and test records | Replacing originals with an undocumented revised version |
| Assign a coordinator | Prevents conflicting supplier, broker, warehouse, and customer messages | Contact and decision log | Asking multiple people to negotiate separate remedies independently |
Detected nonconforming goods arrival also needs a scope decision. The first affected carton may be the only issue, or it may indicate a wider lot, container, product version, or distribution problem. Do not expand or narrow the scope by assumption. Use records, inspection evidence, lot coding, and qualified analysis.
In detected nonconforming goods arrival, preserve first, explain later.
Which records belong in the nonconformance fact file?
A fact file distinguishes verifiable observations from proposed remedies. It is the basis for a supplier discussion, a carrier or warehouse question, an agency response, a technical review, or insurance/legal advice. Keep facts, opinions, and decisions in separate fields.
The detected nonconforming goods arrival file should include the purchase order and approved specifications; approved sample reference; product/SKU/configuration; lot/batch/run; supplier and factory; photos/videos; quantity/location; commercial invoice, packing list, bill of lading or airway bill; entry records; inspection or test report; labels/artwork; complaint/return records; agency notice; and all communications. Link every file to a date and person or source.
| Record category | Examples | Question it answers |
|---|---|---|
| Product identity | SKU, model, product photos, bill of materials, label/package version | What goods are actually affected? |
| Commercial commitment | Purchase order, approved specification, approved sample, contract, calidad agreement | What did the supplier agree to deliver? |
| Production and traceability | Factory, lot/batch/run, production date, component source, inspection record | Which goods may share the issue? |
| Movement and custody | Invoice, packing list, container/airway bill, entry data, warehouse receipt, location | Where are the goods and who controlled them? |
| Condition evidence | Receiving photos, video, inspection report, seal/container record, retained sample link | What was observed and when? |
| Regulatory or authority file | CBP/FDA notice, stated charges/reasons, broker correspondence, response channel | Which authority and procedure may apply? |
| Decision record | Containment action, owner, supplier response, review notes, approved next action | Who decided what, based on which facts? |
For detected nonconforming goods arrival, use the original files as anchors. A corrected invoice, newly translated certificate, or fresh product photo can be relevant, but it should not replace the original evidence. Record when and why a new version was created.
For detected nonconforming goods arrival, facts should survive a disagreement.
How should quarantine, rework, return, export, and disposal be compared?
In detected nonconforming goods arrival, the options may sound simple, but each has different operational, commercial, technical, regulatory, customs, and safety implications. A decision matrix can organize preguntas. It cannot declare a remedy lawful or appropriate for a particular shipment.
Quarantine is a containment control. It holds goods while the facts and authority are understood. Rework may be technically possible, but it can alter the product, labels, evidence, certification position, agency status, or contractual rights. A supplier return or export may depend on customs custody, transport conditions, destination rules, commercial terms, and agency instructions. Disposal or destruction may require control, authorization, documentation, and environmental handling.
| Possible path | Operational purpose | Questions to answer before any action | Evidence and authority check |
|---|---|---|---|
| Quarantine or controlled hold | Stops sale, use, movement, or mixing while facts are assessed | Which units/locations are affected? Who controls the inventory? Could the issue expand? | Hold record, photos, lot traceability, warehouse access controls, agency notice if any |
| Rework, relabel, repair, or repack | May address a documented commercial or regulatory deficiency | Is the action technically appropriate? Is approval required? Does it change product evidence or market status? | Qualified technical/legal/agency guidance, written method, original and revised condition record |
| Return to supplier | May shift physical goods for contractual resolution | Is movement permitted? Who bears costo, title, transport, customs, and liability risk? | Contract, carrier and authority instructions, receiving/shipping record, written supplier acceptance |
| Export or another destination | May be an option in some formal contexts | Is the export authorised and is the receiving market lawful/suitable? Are goods in agency custody? | Written authority/agency instructions and qualified customs/regulatory advice |
| Disposal or destruction | Removes goods only when a controlled and appropriate disposition is established | Who authorises it? What safety/environmental/customs records are required? What evidence must be retained? | Formal instructions, inventory reconciliation, controlled disposition record, professional guidance |
| Customer corrective action | Addresses goods already distributed or sold | Which lots/customers are affected? Is a safety or reporting question present? | Traceability, complaint file, qualified safety/legal review, applicable authority communication |
Detected nonconforming goods arrival should not jump from “we found a problem” to “send it back.” A return can destroy evidence, move goods that are held, create a new transport issue, or fail to address a product that has already entered the market. A rework can also create a new product configuration whose supporting evidence needs review.
For detected nonconforming goods arrival, the option must fit the status.
How do CBP and other-agency actions change the response?
For detected nonconforming goods arrival, if goods are under CBP action, the official notice controls the starting point. 19 CFR 151.16 says CBP decides whether to release or detain merchandise within five business days from presentation for examination and issues a detention notice when it decides to detain or does not release within that period. [1] The notice should state the reason, anticipated length, tests/inquiries, and information that may accelerate disposition. [1]
For detected nonconforming goods arrival involving CBP, preserve the notice and entry file, record the date the goods were presented for examination, and work through the stated communication route and authorized broker or representative. The rule permits an importer or interested party to request CBP testing results and method descriptions in writing, subject to stated exceptions. [1] Do not remove, sample, relabel, repair, export, destroy, or otherwise alter goods in a way that conflicts with the notice or agency control.
A CBP detention notice is not a final admissibility determination. [1] The rule also says it does not apply to detentions effected by CBP on behalf of another agency with authority to decide admissibility. [1] That means the importer must identify whether the relevant authority is CBP, FDA, CPSC, another federal agency, or a separate market authority. One workflow does not govern every hold.
The regulation states that, where otherwise provided by law, CBP may deny entry and permit export in lieu of seizure and forfeiture, with the importer responsible for export expenses. [1] This is not a general instruction to export goods. It is a conditional regulatory provision tied to the actual authority and facts. Seek qualified customs advice before deciding any disposition.
What changes when FDA has detained or refused the goods?
In detected nonconforming goods arrival, FDA-regulated goods require special care because FDA has its own notices and procedures. FDA says it may issue a Notice of Detention and Hearing when imported products appear to violate FDA laws or regulations. The notice identifies the charges and a response date, and FDA describes possible paths such as submitting evidence to overcome the appearance of a violation or submitting a request to recondition the product. [2]
For detected nonconforming goods arrival involving an FDA notice, read the charges, the named contact, and the stated response date. Preserve the affected product and records. Do not begin relabeling, reconditioning, disposal, export, or another substantive remedy based on a generic checklist. FDA’s guidance says a reconditioning proposal may be used in applicable situations, but the proposal is part of an agency process. [2]
FDA explains that an import refusal is its final decision that a detained shipment violates FDA laws and regulations. Its current guidance describes export or destruction under FDA and CBP supervision as the options after a refusal, with the timing and instructions tied to the refusal notice. [3] Those are FDA-specific provisions. They should not be applied to ordinary commercial defects or another agency’s action.
| FDA-related status | What the source says | Buyer control |
|---|---|---|
| Notice of Detention and Hearing | FDA may detain a product that appears to violate FDA law; the notice gives charges and a response date [2] | Preserve notice and evidence, identify authorized respondent, seek qualified FDA/import advice |
| Evidence or testimony | FDA describes the chance to submit information to overcome the appearance of a violation [2] | Submit only accurate, responsive, reviewed information through the stated channel |
| Reconditioning proposal | FDA describes a process to request reconditioning in applicable casos [2] | Do not start rework before appropriate agency permission and professional review |
| Refusal | FDA describes refusal as a final decision and gives FDA-specific export/destruction instructions [3] | Follow actual notice and agency/CBP direction; do not treat as a standard supplier return |
For detected nonconforming goods arrival, the best operational response is precise, not fast in the wrong direction.
How should supplier corrective action and commercial claims be documented?
For detected nonconforming goods arrival, a supplier corrective-action request should begin with facts. Describe the agreed product, observed deviation, affected quantity and lot, location, evidence, immediate containment, and information requested. Ask the supplier to identify root cause, potentially affected production, documents, proposed corrective actions, responsible owner, and prevention step. Do not ask the factory to rewrite records or create a substitute sample to make the file look cleaner.
For detected nonconforming goods arrival, separate commercial questions from regulatory questions. The supplier may offer a price concession, rework, replacement, or return. Those offers do not decide whether goods are safe, lawfully marketable, under agency control, or properly supported by tests and documentation. Keep the contract, purchase order, quality agreement, inspection clause, insurance communications, and title/risk terms in the decision file.
| Claim or corrective-action record | Why it matters | Good control |
|---|---|---|
| Nonconformance statement | Defines the factual deviation from the approved product or agreement | Cite records, photos, lot/quantity, and observation date instead of broad accusations |
| Containment record | Shows what inventory was held and when | Tie each action to SKU, lot, location, owner, and quantity |
| Supplier response | Captures the factory’s proposed cause, scope, and remedy | Preserve original response and ask for evidence supporting its scope conclusion |
| Cost and impact record | Tracks inspection, storage, logistics, customer, and remedy impacts | Use invoices, contractual terms, and written estimates rather than invented totals |
| Technical/regulatory review | Separates product evidence from commercial negotiation | Retain qualified opinions, notices, and the product version addressed |
| Final commercial decision | Records agreed disposition, costs, conditions, and approvals | Do not close the file until movement and evidence consequences are understood |
Detected nonconforming goods arrival is easier to resolve when the supplier sees the same facts the buyer sees. In detected nonconforming goods arrival, a well-organized file is more useful than an emotional demand letter sent before the lot, status, and evidence are understood.
When can a warehouse issue become a wider consumer-safety issue?
A warehouse issue becomes wider when the concern may affect product safety, legality, customers, or goods already distributed. Examples include a component defect, wrong safety label, serious product performance concern, government notice, credible consumer complaint, or evidence that the same lot was shipped through multiple channels. Do not wait for a formal recall notice to trace the affected goods internally.
CPSC says importers, manufacturers, distributors, and retailers may need to conduct a consumer-product recall in the future and emphasizes having a recall plan ready. It describes corrective action plans as potentially involving return, refund/replacement, repair, public notice, or multiple measures. [4] Whether a recall or report is required is a case-specific legal and safety question. A warehouse quarantine is valuable, but it does not solve risk outside the warehouse.
For detected nonconforming goods arrival, pull the product traceability file early. Identify supplier lot, importer lot, cartons/pallets, received units, warehouse inventory, distributor shipments, marketplace fulfillment, customer orders where records permit, returns, and retained samples. Preserve original reports and communications. Seek qualified product-safety and legal advice on reporting, customer communication, corrective action, and regulator contact.
For detected nonconforming goods arrival, traceability turns a concern into a scope question.
What are the limits of an operational decision matrix?
In detected nonconforming goods arrival, a decision matrix can organize questions about speed, cost, evidence, logistics, safety, customer impact, and authority. It cannot decide whether an actual product is compliant, whether a recall must occur, whether an agency will approve reconditioning, whether a court remedy exists, or whether export or destruction is permitted.
Detected nonconforming goods arrival also cannot be resolved from a supplier’s promise alone. It needs the actual product, the relevant notice, applicable product rule, market, contract, current condition, and status of distribution. Different authorities can apply different procedures. The CBP detention rule contains a specific exception for actions taken on behalf of another agency. [1] FDA’s detention and refusal materials are FDA-specific. [2] [3]
Escalate promptly when the issue involves an agency notice, customs custody, safety hazard, potential recall, regulated item, disputed evidence, material product change, high value, potential export/destruction, or a decision that may affect customers. Preserve the facts while the qualified parties assess the appropriate path.
For detected nonconforming goods arrival, the matrix organizes decisions. It does not make them.
Frequently asked questions
What does detected nonconforming goods arrival mean?
Detected nonconforming goods arrival means a buyer has identified goods that may differ from the approved specification, commercial agreement, safety expectation, regulatory requirement, or agency instruction after they arrive. For detected nonconforming goods arrival, the first task is to identify the actual status and preserve evidence.
Should I quarantine all goods after finding one defect?
Do not assume the correct scope. Place potentially affected stock under controlled hold while you use lot, production, packaging, inspection, and distribution records to determine which goods may be connected to the finding.
Can I relabel nonconforming imported goods in my warehouse?
Do not begin relabeling before you identify the product, market, authority, and applicable requirements. If goods are subject to an agency action, relabeling may require an approved process. Seek qualified advice for the specific facts.
Is a CBP detention notice a final refusal of entry?
No. 19 CFR 151.16 states that a CBP detention notice is not a final admissibility determination. Read the notice and identify whether another agency has authority over the goods. [1]
What should I do if FDA detains my shipment?
Preserve the Notice of Detention and Hearing, the products, and all documents. Review the charges and response date, then obtain qualified FDA/import guidance before submitting evidence or proposing reconditioning. FDA describes case-specific response paths in its guidance. [2]
Can I return goods to the supplier after arrival?
It depends on commercial terms, product condition, customs/agency status, transport requirements, destination rules, and the actual authority over the goods. Do not treat a supplier return as automatic if goods are regulated, detained, or under a safety review.
Can I destroy nonconforming goods to avoid storage costs?
Do not destroy goods without confirming authority, evidence-preservation, customs, environmental, safety, and contractual requirements. FDA’s refusal information describes FDA-specific supervised export/destruction actions after refusal. [3]
What documents help support a supplier claim?
Keep the purchase order, approved specification or sample, inspection evidence, product/packaging photos, lot data, shipping and receipt records, correspondence, cost records, and any authority notice. Separate observations from conclusions.
Does a supplier credit resolve a product-safety issue?
No. A commercial credit can address a financial dispute but does not decide safety, compliance, authority custody, customer impact, or reporting obligations.
When does a quality issue become a recall issue?
It may become a wider safety issue when the product could create a hazard, was distributed, or is subject to an authority concern. CPSC describes recall planning and corrective action recursos, but the required action depends on the facts and applicable rules. [4]
Can rework make a refused or detained product acceptable?
Do not assume so. Agency and product rules may require a defined approval process. FDA describes reconditioning proposals in its detention process, while other authorities and ordinary commercial goods can follow different paths. [2]
Referencias
[1] Electronic Code of Federal Regulations, 19 CFR 151.16: Detention of Merchandise
[2] U.S. Food and Drug Administration, Detention and Hearing
[3] U.S. Food and Drug Administration, Import Refusals
[4] U.S. Consumer Product Safety Commission, How to Conduct a Recall
Related reading
Continue with customs detention release planning, lot coding traceability recall, product retention samples programs, and accredited testing lab selection.